Cost Plus Drugs begins testing custom rare-disease treatments at Dallas plant
Cost Plus Drugs has begun using part of its new Dallas factory to make custom medicines for individual patients with rare genetic diseases. The initial shipments, which arrived earlier in 2026, included DNA-like molecules designed by California chemists to…
